← Back to Analyst Consensus 
CVKD Buy
Cadrenal Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 7, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 16, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Nov 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $32 | 44% |
| Jun 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Mar 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Dec 18, 2023 | Noble Capital Markets | initiate | — → Outperform | $4 | 63% |
| Nov 20, 2023 | HC Wainwright & Co. | initiate | — → Buy | $3 | 44% |
Price Target Trend
Apr 1, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days